Nathan F. Schachter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathan F. Schachter has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- A. Sorana Morrissy
Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
1 shared publication - Aaron Kucharczuk
Program in Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Canada
1 shared publication - Adam J. Dupuy
Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA
1 shared publication Amanda J. Loch
Program in Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Canada
1 shared publication- Charles M. Perou
University of North Carolina at Chapel Hill 1 Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina
1 shared publication Christian A. Lee
Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Canada
1 shared publication
Latest Publications
- Open Access
- 2 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-19
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
The most common events in breast cancer (BC) involve chromosome arm losses and gains. Here we describe identification of 1089 gene-centric common insertion sites (gCIS) from transposon-based screens in 8 mouse models of BC. Some gCIS are driver-specific, others driver non-specific, and still others associated with tumor histology. Processes affected by driver-specific and histology-specific mutations include well-known cancer pathways. Driver non-specific gCIS target the Mediator complex, Ca++ signaling, Cyclin D turnover, RNA-metabolism among other processes. Most gCIS show single allele disruption and many map to genomic regions showing high-frequency hemizygous loss in human BC. Two gCIS, Nf1 and Trps1, show synthetic haploinsufficient tumor suppressor activity. Many gCIS act on the same pathway responsible for tumor initiation, thereby selecting and sculpting just enough and just right signaling. These data highlight ~1000 genes with predicted conditional haploinsufficient tumor suppressor function and the potential to promote chromosome arm loss in BC.
- 2 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-19
Open AccessSingle allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
The most common events in breast cancer (BC) involve chromosome arm losses and gains. Here we describe identification of 1089 gene-centric common insertion sites (gCIS) from transposon-based screens in 8 mouse models of BC. Some gCIS are driver-specific, others driver non-specific, and still others associated with tumor histology. Processes affected by driver-specific and histology-specific mutations include well-known cancer pathways. Driver non-specific gCIS target the Mediator complex, Ca++ signaling, Cyclin D turnover, RNA-metabolism among other processes. Most gCIS show single allele disruption and many map to genomic regions showing high-frequency hemizygous loss in human BC. Two gCIS, Nf1 and Trps1, show synthetic haploinsufficient tumor suppressor activity. Many gCIS act on the same pathway responsible for tumor initiation, thereby selecting and sculpting just enough and just right signaling. These data highlight ~1000 genes with predicted conditional haploinsufficient tumor suppressor function and the potential to promote chromosome arm loss in BC.